Advertisement

Index by Author

April 1998; 21 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abraira, Carlos

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574
    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  2. Acampora, Rita

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  3. Adler, Amanda I

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  4. Adlerberth, Annika M

    • Diabetes and Long-Term Risk of Mortality From Coronary and Other Causes in Middle-Aged Swedish Men: A general population study Diabetes Care April 1998 21:539-545; doi:10.2337/diacare.21.4.539

  5. Agrawal, Lily

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510

  6. Akaoka, Ieo

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  7. Albisser, A Michael

    • An Electronic Case Manager for Diabetes Control Diabetes Care April 1998 21:591-596; doi:10.2337/diacare.21.4.591

  8. Amemiya, Shin

    • Constant Infused Glucose Regimen During the Recovery Phase of Diabetic Ketoacidosis in Children and Adolescents With IDDM Diabetes Care April 1998 21:676-677; doi:10.2337/diacare.21.4.676

  9. Andersen, Henning

    • Muscular Endurance in Long-Term IDDM Patients Diabetes Care April 1998 21:604-609; doi:10.2337/diacare.21.4.604

  10. Aoji, Osamu

    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  11. Aono, Toshihiro

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  12. Arakaki, Richard F

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

B

  1. Bates, Peter C

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  2. Becker, Dorothy J

    • The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population Diabetes Care April 1998 21:610-614; doi:10.2337/diacare.21.4.610

  3. Berger, Bo

    • The Prevalence of Diabetes in a Swedish Population of 280,411 Inhabitants: A report from the Skaraborg Diabetes Registry Diabetes Care April 1998 21:546-548; doi:10.2337/diacare.21.4.546

  4. Birkett, Martin A

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  5. Bloomgarden, Zachary T

    • International Diabetes Federation Meeting, 1997, and Metropolitan Diabetes Society of New York Meeting, November 1997: Approaches to treatment and other topics in type 1 diabetes; Genetic heterogeneity of diabetes Diabetes Care April 1998 21:658-665; doi:10.2337/diacare.21.4.658

  6. Brambilla, Giorgio

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  7. Broadhurst, Robin J

    • Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637

  8. Brunner, Gernot A

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  9. Buck, Christian

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  10. Byington, Robert P

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  11. Byrd-Holt, Danita D

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

C

  1. Calia, Patrizia

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  2. Califf, Robert M

    • Hypertension and Diabetes and the Fosinopril Versus Amlodipine Cardiovascular Events Trial (FACET): More ammunition against surrogate end points Diabetes Care April 1998 21:655-657; doi:10.2337/diacare.21.4.655

  3. Cario, Holger

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  4. Chang, Healani K

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

  5. Chang, Yue-Fang

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525
    • The Prevalence of Diabetes in a Swedish Population of 280,411 Inhabitants: A report from the Skaraborg Diabetes Registry Diabetes Care April 1998 21:546-548; doi:10.2337/diacare.21.4.546

  6. Chung, Yun E

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

  7. Clark, Charles M, Jr

    • How Should We Respond to the Worldwide Diabetes Epidemic? Diabetes Care April 1998 21:475-476; doi:10.2337/diacare.21.4.475

  8. Clelia, Paratore

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  9. Colwell, John A

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574
    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  10. Comstock, John

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  11. Comstock, John P

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  12. Coppola, Ludovico

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  13. Cowie, Catherine C

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  14. Curb, J David

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

D

  1. D'Onofrio, Felice

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  2. David, Michael

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  3. Davis, Timothy M E

    • Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637

  4. Debatin, Klaus-Michael

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  5. Desfaits, Anne-Cécile

    • Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment Diabetes Care April 1998 21:487-493; doi:10.2337/diacare.21.4.487

  6. Dhanjil, Surinder

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  7. Diamond, Judith R

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  8. Dorman, Janice S

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

E

  1. Ebbesson, Lars

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  2. Ebbesson, Sven O K

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  3. Eberhardt, Mark S

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  4. El-Kebbi, Imad M

    • Diabetes in Urban African-Americans. VI. Utility of Fasting or Random Glucose in Identifying Poor Glycemic Control Diabetes Care April 1998 21:501-505; doi:10.2337/diacare.21.4.501

  5. Elkeles, Robert S

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  6. Ellmerer, Martin

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  7. Emanuele, Nicholas

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  8. Emanuele, Nicholas V

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  9. Equiluz-Bruck, Susanna

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  10. Erbey, John R

    • The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population Diabetes Care April 1998 21:610-614; doi:10.2337/diacare.21.4.610

F

  1. Faglia, Ezio

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  2. Favales, Fabrizio

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  3. Feher, Michael D

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  4. Fineman, Mark S

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  5. Flegal, Katherine M

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  6. Friedberg, Cylla E

    • Fish Oil and Glycemic Control in Diabetes: A meta-analysis Diabetes Care April 1998 21:494-500; doi:10.2337/diacare.21.4.494

  7. Fujii, Satoru

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  8. Fujishima, Masatoshi

    • Serum Leptin Levels in Smokers With Type 2 Diabetes Diabetes Care April 1998 21:516-517; doi:10.2337/diacare.21.4.516

  9. Fujita, Takasi

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  10. Fukui, Michiaki

    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  11. Funato, Hirono

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  12. Furth, Eugene D

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

G

  1. Gallina, Daniel L

    • Diabetes in Urban African-Americans. VI. Utility of Fasting or Random Glucose in Identifying Poor Glycemic Control Diabetes Care April 1998 21:501-505; doi:10.2337/diacare.21.4.501

  2. Giugliano, Dario

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  3. Giunta, Riccardo

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  4. Gold, Ann E

    • The Effect of Glycemic Control in the Pre-Conception Period and Early Pregnancy on Birth Weight in Women With IDDM Diabetes Care April 1998 21:535-538; doi:10.2337/diacare.21.4.535

  5. Goldberg, Ronald B

    • An Electronic Case Manager for Diabetes Control Diabetes Care April 1998 21:591-596; doi:10.2337/diacare.21.4.591

  6. Goldstein, David E

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  7. Go, Oskar T

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  8. Grandinetti, Andrew

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

  9. Granger, Christopher B

    • Hypertension and Diabetes and the Fosinopril Versus Amlodipine Cardiovascular Events Trial (FACET): More ammunition against surrogate end points Diabetes Care April 1998 21:655-657; doi:10.2337/diacare.21.4.655

  10. Grobbee, Diederick E

    • Fish Oil and Glycemic Control in Diabetes: A meta-analysis Diabetes Care April 1998 21:494-500; doi:10.2337/diacare.21.4.494

  11. Guarisco, Riccardo

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

H

  1. Hamada, Michiko

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  2. Harris, Maureen I

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  3. Havelec, Liselotte

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  4. Hayakawa, Nobuki

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  5. Hayashi, Ritsuko

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  6. Heine, Robert J

    • Fish Oil and Glycemic Control in Diabetes: A meta-analysis Diabetes Care April 1998 21:494-500; doi:10.2337/diacare.21.4.494

  7. Helve, Eero

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  8. Henderson, William G

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  9. Hobbs, Michael S T

    • Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637

  10. Hodak, Emmilia

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  11. Holl, Reinhard W

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  12. Hong, Sung K

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

I

  1. Ilmonen, Marja

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  2. Imanishi, Masahito

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  3. Imperatore, Gluseppina

    • Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649

  4. Inoue, Tae

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  5. Iovine, Ciro

    • Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649

  6. Itoh, Mitsuyasu

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  7. Iwamoto, Kazuhide

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

J

  1. James, Sherman A

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

  2. Jamjoum, Lama

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

  3. Jamrozik, Konrad

    • Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637

  4. Janssen, Martien J F M

    • Fish Oil and Glycemic Control in Diabetes: A meta-analysis Diabetes Care April 1998 21:494-500; doi:10.2337/diacare.21.4.494

K

  1. Kaarsalo, Esko

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  2. Kajiyama, Shizuo

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

  3. Kakizawa, Hiroaki

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  4. Karp, Moshe

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  5. Kawasaki, Takahiro

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  6. Khazanie, Prabhaker G

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

  7. Kilkki, Esa

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  8. Kim, Hong-Kyu

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

  9. Kim, Sang W

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

  10. Kimura, Genjiro

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  11. Kinney, Everett K

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

  12. Kitagawa, Yoshihiro

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

  13. Knobler, Robert

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  14. Koda, Joy E

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  15. Kohne, Elisabeth

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  16. Kondo, Motoharu

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615
    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  17. Konishi, Yoshio

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  18. Koshibu, Eri

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  19. Krejs, Guenter J

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  20. Kuller, Lewis H

    • The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population Diabetes Care April 1998 21:610-614; doi:10.2337/diacare.21.4.610

L

  1. Laakso, Markku

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  2. LaPorte, Ronald E

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

  3. Latha, E

    • Evaluation of the Use of Fasting Plasma Glucose as a New Diagnostic Criterion for Diabetes in Asian Indian Population Diabetes Care April 1998 21:666-667; doi:10.2337/diacare.21.4.666

  4. Lee, Ki-Up

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

  5. Levin, Seymour

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  6. Levin, Seymour R

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  7. Li, Tianlin

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

  8. Little, Jill

    • The Effect of Glycemic Control in the Pre-Conception Period and Early Pregnancy on Birth Weight in Women With IDDM Diabetes Care April 1998 21:535-538; doi:10.2337/diacare.21.4.535

  9. Little, Randie R

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  10. Li, Yurui

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

M

  1. Mahmood, Shahid

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  2. Makino, Masahiro

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

  3. Makino, Masaki

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  4. Marfella, Raffaele

    • Effects of Perindopril and Carvedilol on Endothelium-Dependent Vascular Functions in Patients With Diabetes and Hypertension Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631

  5. Mather, Hugh

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  6. Mau, Marjorie K

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

  7. Mauro, Patrizia Di

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  8. Mayer, Ann Marie

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  9. Meneghini, Luigi F

    • An Electronic Case Manager for Diabetes Control Diabetes Care April 1998 21:591-596; doi:10.2337/diacare.21.4.591

  10. Mintz, Daniel H

    • An Electronic Case Manager for Diabetes Control Diabetes Care April 1998 21:591-596; doi:10.2337/diacare.21.4.591

  11. Miyashita, Hideo

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  12. Morabito, Alberto

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

N

  1. Nagasaka, Akio

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  2. Nagata, Mutsuko

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  3. Nakamura, Naoto

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615
    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  4. Nakano, Koji

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615
    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  5. Nicolaides, Andrew N

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  6. Nuttall, Frank

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  7. Nuttall, Frank Q

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

O

  1. O'Rahilly, Stephen

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  2. Obayashi, Hiroshi

    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  3. Ogata, Nobuyuki

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  4. Ohgaki, Kimiko

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

  5. Orchard, Trevor J

    • The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population Diabetes Care April 1998 21:610-614; doi:10.2337/diacare.21.4.610

P

  1. Pahor, Marco

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  2. Park, Joong-Yeol

    • Incidence and Determinants of Microalbuminuria in Koreans With Type 2 Diabetes Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530

  3. Parsons, Richard W

    • Arrhythmias and Mortality After Myocardial Infarction in Diabetic Patients: Relationship to diabetes treatment Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637

  4. Phillips, Lawrence S

    • Diabetes in Urban African-Americans. VI. Utility of Fasting or Random Glucose in Identifying Poor Glycemic Control Diabetes Care April 1998 21:501-505; doi:10.2337/diacare.21.4.501

  5. Pieber, Thomas R

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  6. Poulter, Clare

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

Q

  1. Quarantiello, Antonella

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  2. Quehenberger, Franz

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

R

  1. Raghunathan, T E

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

  2. Ramachandran, A

    • Evaluation of the Use of Fasting Plasma Glucose as a New Diagnostic Criterion for Diabetes in Asian Indian Population Diabetes Care April 1998 21:666-667; doi:10.2337/diacare.21.4.666

  3. Rampoldi, Antonio

    • Angiographic Evaluation of Peripheral Arterial Occlusive Disease and Its Role as a Prognostic Determinant for Major Amputation in Diabetic Subjects With Foot Ulcers Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625

  4. Reilly, Rena

    • The Effect of Glycemic Control in the Pre-Conception Period and Early Pregnancy on Birth Weight in Women With IDDM Diabetes Care April 1998 21:535-538; doi:10.2337/diacare.21.4.535

  5. Renier, Geneviève

    • Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment Diabetes Care April 1998 21:487-493; doi:10.2337/diacare.21.4.487

  6. Riccardi, Gabriele

    • Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649

  7. Richmond, William

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  8. Risica, Patricia M

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  9. Rivellese, Angela A

    • Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649

  10. Robbins, David C

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  11. Rosengren, Annika

    • Diabetes and Long-Term Risk of Mortality From Coronary and Other Causes in Middle-Aged Swedish Men: A general population study Diabetes Care April 1998 21:539-545; doi:10.2337/diacare.21.4.539

S

  1. Sagum, Rebecca

    • Prevalence of Glucose Intolerance Among Native Hawaiians in Two Rural Communities Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549

  2. Saltevo, Juha

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  3. Sandholzer, Klaudia

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  4. Sato, Toshihiko

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  5. Sawada, Manabu

    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  6. Sawin, Clark

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  7. Sawin, Clark T

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  8. Schaupp, Lukas

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  9. Schernthaner, Guntram

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  10. Schindl, Andreas

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  11. Schindl, Liesbeth

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  12. Schindl, Martin

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  13. Schön, Heidemarie

    • Low-Intensity Laser Irradiation Improves Skin Circulation in Patients With Diabetic Microangiopathy Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580

  14. Schraer, Cynthia D

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  15. SENDCAP Study Group

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  16. Sendlhofer, Gerald

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  17. Serri, Omar

    • Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment Diabetes Care April 1998 21:487-493; doi:10.2337/diacare.21.4.487

  18. Sharp, Patrick

    • Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641

  19. Shigeta, Hirofumi

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615
    • Antibodies to GAD in Elderly Patients With Previously Diagnosed NIDDM Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675

  20. Shinohara, Rikio

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

  21. Shraga, Ilana

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  22. Shubnikof, Eugene V

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  23. Silbert, Cynthia

    • A Critical Issue: Intensive insulin treatment and macrovascular disease Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669

  24. Silbert, Cynthia K

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  25. Snehalatha, C

    • Evaluation of the Use of Fasting Plasma Glucose as a New Diagnostic Criterion for Diabetes in Asian Indian Population Diabetes Care April 1998 21:666-667; doi:10.2337/diacare.21.4.666

  26. Sprecher, Eliott

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  27. Stenström, Gunnar

    • The Prevalence of Diabetes in a Swedish Population of 280,411 Inhabitants: A report from the Skaraborg Diabetes Registry Diabetes Care April 1998 21:546-548; doi:10.2337/diacare.21.4.546

  28. Strogatz, David S

    • Physical Activity and NIDDM in African-Americans: The Pitt County Study Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555

  29. Strollo, Felice

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  30. Strollo, Giovanna

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  31. Sundkvist, Göran

    • The Prevalence of Diabetes in a Swedish Population of 280,411 Inhabitants: A report from the Skaraborg Diabetes Registry Diabetes Care April 1998 21:546-548; doi:10.2337/diacare.21.4.546

  32. Sun, Wei

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

  33. Swinn, Robert

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

T

  1. Takanashi, Yoshiaki

    • Ratio of Motor Nerve Conduction Velocity to F-Wave Conduction Velocity in Diabetic Neuropathy Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615

  2. Tanaka, Shiro

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  3. Tatti, Patrizio

    • Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597

  4. Taylor, Kevin

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  5. The Study Group

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  6. Thon, Angelika

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  7. Tikkanen, Matti J

    • Treatment of Hypercholesterolemia and Combined Hyperlipidemia With Simvastatin and Gemfibrozil in Patients With NIPPM: A multicenter comparison study Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477

  8. Trajanoski, Zlatko

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

U

  1. Uchimura, Keiko

    • Changes in Erythrocyte Sorbitol Concentrations Measured Using an Improved Assay System in Patients With Diabetic Complications and Treated With Aldose Reductase Inhibitor Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672

V

  1. Vaccaro, Olga

    • Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649

  2. VA CSDM Group

    • Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
    • Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574

  3. Vardi, Pnina

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

  4. Vijay, V

    • Evaluation of the Use of Fasting Plasma Glucose as a New Diagnostic Criterion for Diabetes in Asian Indian Population Diabetes Care April 1998 21:666-667; doi:10.2337/diacare.21.4.666

W

  1. Wach, Paul

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

  2. Wakisaka, Masanori

    • Serum Leptin Levels in Smokers With Type 2 Diabetes Diabetes Care April 1998 21:516-517; doi:10.2337/diacare.21.4.516

  3. Walker, James D

    • The Effect of Glycemic Control in the Pre-Conception Period and Early Pregnancy on Birth Weight in Women With IDDM Diabetes Care April 1998 21:535-538; doi:10.2337/diacare.21.4.535

  4. Wang, Kean

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

  5. Wareham, Nicholas J

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  6. Wein, Wolfgang

    • Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570

  7. Wiedmeyer, Hsiao-Mei

    • Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518

  8. Wilhelmsen, Lars

    • Diabetes and Long-Term Risk of Mortality From Coronary and Other Causes in Middle-Aged Swedish Men: A general population study Diabetes Care April 1998 21:539-545; doi:10.2337/diacare.21.4.539

  9. Williams, Desmond E M

    • Gestational Diabetes Mellitus Is Associated With an Increase in the Total Concentration of Amylin Molecules Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668

  10. Wolever, Thomas M S

    • Assessing the Antihyperglycemic Effect of Acarbose: Solid or liquid test meal? Diabetes Care April 1998 21:667-668; doi:10.2337/diacare.21.4.667

  11. Wolf, Anna

    • Diagnosis of Diabetes in Cystic Fibrosis and Thalassemia Major Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671

  12. Wutte, Andrea

    • Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585

Y

  1. Yamanouchi, Toshikazu

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  2. Yang, Ze

    • Childhood Diabetes in China: Enormous variation by place and ethnic group Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525

  3. Yeh, Jeunliang

    • Diabetes and Impaired Glucose Tolerance in Three Alaskan Eskimo Populations: The Alaska-Siberia Project Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563

  4. Yoshimura, Tomoe

    • Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619

  5. Yoshinari, Mototaka

    • Serum Leptin Levels in Smokers With Type 2 Diabetes Diabetes Care April 1998 21:516-517; doi:10.2337/diacare.21.4.516

  6. Yoshioka, Katsunobu

    • Glomerular Charge and Size Selectivity Assessed by Changes in Salt Intake in Type 2 Diabetic Patients Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482

  7. Yosipovitch, Gil

    • The Prevalence of Cutaneous Manifestations in IDDM Patients and Their Association With Diabetes Risk Factors and Microvascular Complications Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506

Z

  1. Ziemer, David C

    • Diabetes in Urban African-Americans. VI. Utility of Fasting or Random Glucose in Identifying Poor Glycemic Control Diabetes Care April 1998 21:501-505; doi:10.2337/diacare.21.4.501

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement